Iran has been under US and international financial sanctions for years. These make it very difficult to import raw pharmaceutical ingredients and finished drug products. Even medicines that are technically legal to import face banking and payment barriers - foreign suppliers cannot easily receive payment from Iranian companies.
The Iranian rial has lost enormous value. Importing medications (or the active pharmaceutical ingredients to manufacture them locally) has become extremely expensive in local currency terms. Many pharmacies and distributors cannot afford to stock drugs that require hard currency to purchase.
The US-Israel conflict with Iran that began in early 2026 severely disrupted supply chains further:
Iran's government reportedly owes hundreds of millions of dollars to pharmacies through the insurance/reimbursement system. Many pharmacies have reduced their stock orders as a result.
Even where triamcinolone is manufactured domestically in Iran, production depends on imported active pharmaceutical ingredients (APIs) and packaging materials (aluminum tubes, etc.). Both categories have become harder to source.
If you need a topical corticosteroid and triamcinolone is unavailable,
betamethasone valerate (پماد بتامتازون) or
mometasone (پماد مومتازون) are pharmacologically similar options that may still be on pharmacy shelves - ask your pharmacist or doctor for a substitution. The
darooyab.ir website is a useful Iranian tool to check which pharmacies in Tehran currently have a specific drug in stock.